NEW YORK – Experts involved in the Clinical Interpretation of Variants in Cancer (CIViC) database are in discussions with the US Food and Drug Administration about garnering regulatory recognition for the repository.
CIViC was launched four years ago by brothers Obi and Malachi Griffith at Washington University School of Medicine, St. Louis, as an open-source, open-access repository of variants that the life sciences community could curate and interpret collaboratively, and use to advance precision cancer medicine.